Food additive carrageenan: Part II: A critical review of carrageenan in vivo safety studies

References

• Abraham R, Benitz KF, Mankes R, Rosenblum I. (1985). Chronic and subchronic effects of various forms of carrageenan in rats. Ecotoxicol Environ Saf, 10, 173–83
   PubMedGoogle Scholar
• Abraham R, Fabian RJ, Golberg L, Coulston F. (1974). Role of lysosomes in carrageenan-induced cecal ulceration. Gastroenterology 67, 1169--81
   Google Scholar
• Abraham R, Golberg L, Coulston F. (1972). Uptake and storage of degraded carrageenan in lysosomes of reticuloendothelial cells of the Rhesus monkey, Macaca Mulatta. Exp Mol Path, 17, 77–93
   PubMed Web of Science ®Google Scholar
• Albany Medical College, Institute of Comparative and Human Toxicology. (1975). Unpublished reports
   Google Scholar
• Albany Medical College, Institute of Comparative and Human Toxicology. (1983). Unpublished reports
   Google Scholar
• American Academy of Pediatrics. (2000). Hypoallergenic infant formulas. Committee on Nutrition. Pediatrics, 106, 346–9
   PubMed Web of Science ®Google Scholar
• Arakawa S, Ito M, Tejima S. (1988). Promoter function of carrageenan on development of colonic tumors induced by 1,2-dimethylhydrazine in rats. J Nutr Sci Vitamin, 34, 577–85
   PubMed Web of Science ®Google Scholar
• Arakawa S, Okumura M, Yamada S, et al. (1986). Enhancing effect of carrageenan on the induction of rat colonic tumors by 1,2-dimethylhydrazine and its relation to B-glucuronidase activities in feces and other tissues. J Nutr Sci Vitamin, 32, 481–5
   PubMed Web of Science ®Google Scholar
• Bailey DE, Morgareidge K. (1973). Teratologic evaluation of carrageenan salts in rats and hamsters. Food and Drug Research Laboratory Project No. N-73-02, Waverly, NY, USA (Unpublished)
   Google Scholar
• Bash JA, Cochran FR. (1980). Carrageenan-induced suppression of T lymphocyte proliferation in the rat: in vitro production of a suppressor factor by peritoneal macrophages. J Reticuloendothel Soc, 28, 203–11
   PubMedGoogle Scholar
• Bash JA, Vago JR. (1980). Carrageenan-induced suppression of T lymphocyte proliferation in the rat: in vivo suppression induced by oral administration. J Reticuloendothel Soc, 28, 213–21
   PubMedGoogle Scholar
• Benitz KF, Golberg L, Coulston F. (1973). Intestinal effects of carrageenans in the Rhesus monkey. Food Cosmet Toxicol, 11, 565–75
   PubMedGoogle Scholar
• Bhattacharyya S, O-Sullivan I, Katyal S, et al. (2012). Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice. Diabetologia, 55, 194–203
   PubMed Web of Science ®Google Scholar
• Bixler H. (2013). Food safety: refuting myths about carrageenan. Food Processing. Available from http://www.foodprocessing.com/articles/2013/refuting-myths-about-carrageenan.html
   Google Scholar
• Blakemore WR, Harpell AR. (2010). Carrageenan. In: Imeson A, ed. Food Stabilisers, Thickeners and Gelling Agent, Chapter 5. Wiley-Blackwell, Blackwell Publishing Ltd. Published Online, 73--94
   Google Scholar
• Bonfils S. (1970). Carrageenan and the Human Gut. Lancet, 2, 414
   Google Scholar
• Borsches MW, Barrett-Reis B, Baggs GE, Williams TA. (2002). Growth of healthy term infants fed a powdered casein hydrolysate-based formula (CHF). FASEB J, 16, A66 (Abstract 497.7)
   Google Scholar
• Canada Gazette (2004). Vol. 138, No. 20. May 15, Item A.5. Available from: http://www.hc-sc.gc.ca/fn-an/securit/addit/list/4-emulsif-eng.php
   Google Scholar
• Capron I, Yvon M, Muller G. (1996). In vitro gastric stability of carrageenan. Food Hydrocolloids, 10, 239–44
   Web of Science ®Google Scholar
• Carthew P. (2002). Safety of carrageenan in foods. Correspond Environ Health Perspect, 110, A176
   PubMedGoogle Scholar
• Code of Federal Regulations (CFR). Title 21 – Food and Drugs, Part 172.620 Carrageenan
   Google Scholar
• Cohen S, Ito N. (2002). A critical review of the toxicological effects of carrageenan and processed eucheuma seaweed on the gastrointestinal tract. Crit Rev Toxicol, 32, 413–44
   PubMed Web of Science ®Google Scholar
• Collins TFX, Black TN, Prew JH. (1977a). Long-term effects of calcium carrageenan in rats. I. Effects on reproduction. Food Cosmet Toxicol, 15, 533–8
   PubMedGoogle Scholar
• Collins TFX, Black TN, Prew JH. (1977b). Long-term effects of calcium carrageenan in rats. II. Effects on fetal development. Food Cosmet Toxicol, 15, 539–45
   PubMedGoogle Scholar
• Commission Directive. (2004). 2004/45/EC of 16 April 2004 amending Directive 96/77/EC laying down specific purity criteria on food additives other than colours and sweetners. Official J Eur Union, 47, 20 April 2004, L113/19--L113/21
   Google Scholar
• Commission Regulation. (2012). 2031/2012 of 9 March, 2012. Official J Eur Union L83, 55, L 83/140–1
   Google Scholar
• Corpet DE, Tache S, Preclaire M. (1997). Carrageenan given as a jelly, does not initiate, but promotes the growth of aberrant crypt foci in the rat colon. Cancer Lett, 114, 53–5
   PubMedGoogle Scholar
• Coste M, Dubuquoy C, Tome D. (1989). Effect of systemic and orally administered iota-carrageenan on ovalbumin-specific antibody response in the rat. Int Arch Allergy Appl Immunol, 88, 474–6
   PubMedGoogle Scholar
• Dewar ET, Maddy ML. (1970). Faecal excretion of degraded and native carrageenan by the young rat. J Pharm Pharmacol, 22, 791–3
   PubMedGoogle Scholar
• Donnelly ET, Bardwell H, Thomas GA, et al. (2004a). Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical. Carcinogenesis, 25, 847–55
   PubMed Web of Science ®Google Scholar
• Donnelly ET, Bardwell H, Thomas GA, et al. (2004b). Colonic crypt stem cell mutation indices (CCSCMI) in a predictive risk assessment model for diet related chemicals. Gastroenterology, 126, A505
   Google Scholar
• Donnelly ET, Bardwell H, Thomas GA, et al. (2004c). Dietary interactions and inception of colonic tumourigenesis. Gut, 53, A121
   Google Scholar
• Donnelly ET, Bardwell H, Thomas GA, et al. (2005). Metallothioein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. Br J Cancer, 92, 2160–5
   PubMed Web of Science ®Google Scholar
• Elsenhans B, Caspary WF. (1989). Differential changes in the urinary excretion of two orally administered polyethylene glycol markers (PEG 900 and PEG 4000) in rats after feeding various carbohydrate gelling agents. J Nutr, 119, 380–7
   PubMedGoogle Scholar
• Engster M, Abraham R. (1976). Cecal response to different molecular weights and types of carrageenan in the guinea pig. Toxicol Appl Pharmacol, 38, 265–82
   PubMed Web of Science ®Google Scholar
• European Commission (2003). Health & Consumer Protection Directorate-General, Opinion of the Scientific Committee on Food on Carrageenan, SCF/CS/ADD/EMU/199 Final, Available from: http://ec.europa.eu/food/fs/sc/scf/out164_en.pdf
   Google Scholar
• Federal Register (FR). (1961). 26FR 9711
   Google Scholar
• Food and Agriculture Organization of the United Nations. (2007). Combined Compendium of Food Additive Specifications; CGN – 68th session of JECFA, 2007
   Google Scholar
• Food and Drug Administration (FDA). (1972a). Mutagenic evaluation of compound FDA 71-3, sodium carrageenan. PB 254 471
   Google Scholar
• Food and Drug Administration (FDA). (1972b). Study of mutagenic effects of calcium carrageenan (FDA No. 71-5). PB 221 820
   Google Scholar
• Food and Drug Administration. (1972c). Generally Recognized As Safe (GRAS) Food Ingredients – Carrageenan. PB 221 206
   Google Scholar
• Food and Drug Administration (FDA). (1973). Evaluation of the health aspects of carrageenan as a food ingredient. PB 266 877
   Google Scholar
• Food and Drug Administration (FDA). (1975). Mutagenic evaluation of compounds FDA 71-3, 977007-70-7, Sodium Carrageenan (Viscarin) PB 254 515
   Google Scholar
• Food and Drug Administration (FDA). (2000). Toxicological principles for the safety assessment of food ingredients: Redbook. Available from: http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/ingredientsadditivesgraspackaging/ucm2006826.htm
   Google Scholar
• Food and Drug Administration (FDA). (2012). Letter to Dr. Joanne K. Tobacman, Docket FDA-2008-8P-0347, dated June 11, 2012, from Ted Eklin, Acting Deputy Director for Operations, Center for Food Safety and Applied Nutrition
   Google Scholar
• Food and Drug Research Laboratories, Inc. (FDRL). (1972a). Teratologic Evaluation of FDA 71-3 (Sodium Carrageenate). Prepared for the Food and Drug Administration, PB 221 812
   Google Scholar
• Food and Drug Research Laboratories, Inc. (FDRL). (1972b). Teratologic Evaluation of FDA 71-5 (Calcium Carrageenate). Prepared for the Food and Drug Administration, PB 221 787
   Google Scholar
• Food Chemicals Codex. (2013). FCC monographs, 8th ed., 219–28
   Google Scholar
• Friedman I, Douglas CD. (1960). Unpublished summary report submitted by Marine Colloids, Inc
   Google Scholar
• Frossard CP, Hauser C, Eigenmann PA. (2001). Oral carrageenan induces antigen-dependent oral tolerance: prevention of Anaphylaxis and induction of lymphocyte anergy in a murine model of food allergy. Pediatr Res, 49, 417–22
   PubMedGoogle Scholar
• Glicksman M. (ed.) (1969). Seaweed extracts. In: Gum Technology in the Food Industry, Chapter 8, Academic Press, 214--235
   Google Scholar
• Grasso P, Gangolli SD, Butterworth KR, Wright MG. (1975). Studies on degraded carrageenan in rats and guinea-pigs. Food Cosmet Toxicol, 11, 195--201
   Google Scholar
• Grasso P, Sharratt M, Carpanini FMB, Gangolli SD. (1973). Studies on carrageenan and large-bowel ulceration in mammals. Food Cosmet Toxicol, 11, 555–64
   PubMedGoogle Scholar
• Hagiwara A, Miyashia K, Nakanishi T, et al. (2001). Lack of tumor promoting effects of carrageenan on1,2-dimethylhydrazine-induced colorectal carcinogenesis in male F344 rats. J Toxicol Pathol, 14, 37–43
   Google Scholar
• Harmuth-Hoene AE, Schelenz R. (1980). Effect of dietary fiber on mineral absorption in growing rats. J Nutr, 110, 1774–84
   PubMed Web of Science ®Google Scholar
• Hawkins WW, Yaphe WW. (1965). Carrageenan as a dietary constituent of the rat: faecal excretion, nitrogen absorption and growth. Can J Biochem, 43, 479–84
   PubMedGoogle Scholar
• Hirono I, Sumi Y, Kuhara K, Miyakawa M. (1981). Effect of degraded carrageenan on the intestine in germfree rats. Toxicol Lett, 8, 207--12
   Google Scholar
• Hopkins J. (1981). Carcinogenicity of carrageenan. Food Cosmet Toxicol, 19, 779–88
   PubMedGoogle Scholar
• International Agency for Research on Cancer (IARC) Monograph. (1983). Carrageenan, 31, 79–94
   Google Scholar
• International Programme on Chemical Safety in cooperation with the Joint FAO/WHO Expert Committee on Food Additives (JECFA). (1987). Principles for the safety assessment of food additives and contaminants in food, environmental heath criteria 70. Geneva: WHO
   Google Scholar
• International Programme on Chemical Safety (IPCS) Environmental Health Criteria 240. (2009). Principals and methods for the risk assessment of chemicals in food. Available from http://www.who.int/foodsafety/chem/principles/en/index1.html
   Google Scholar
• Ishioka T, Kuwabara N, Oohashi Y, Wakabayashi K. (1986). Induction of colorectal tumors in rats by sulfated polysaccharides. Crit Rev Toxicol, 17, 215--44
   Google Scholar
• Jackson LI. (1997). Salmonella mutation test (Ames test) with a semi-refined carrageenan from two sources. Unpublished BIBAR Report No. 3160/2/1/97 from BIBRA International, Carshalton, Surrey, United Kingdom. Submitted to WHO by Dr. H.J. Bixler, Seaweed Industry Association of the Phillipines, Searsport, Maine, United States
   Google Scholar
• Japan Food Additives Association (2009). Japan’s Specifications for Food Additives, 8th ed., the Ministry of Health and Welfare, 344
   Google Scholar
• JECFA: Joint FAO/WHO Expert Committee on Food Additives. (1974). Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents. WHO Food Add Ser, 5, 386–410
   Google Scholar
• JECFA: Joint FAO/WHO Expert Committee on Food Additives. (1999). Toxicological evaluation of certain food additives, including anticaking agents, antimicroials, antioxidants, emulsifiers and thickening agents. WHO Food Addi Ser, 42, 147–69
   Google Scholar
• JECFA: Joint FAO/WHO Expert Committee on Food Additives (2002). Fifty-seventh report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 909
   Google Scholar
• JECFA: Joint FAO/WHO Expert Committee on Food Additives. (2008). Sixty-eighth Report of the Joint FAO/WHO Expert Committee on Food Additives; Evaluation of Certain Food Additives and Contaminants. WHO Technical Report Series, 947, 32–7
   Google Scholar
• Kasper H, Rabast U, Fassl H, Fehle F. (1979). The effect of dietary fiber on the postprandial serum vitamin A concentration in man. Am J Clin Nutr, 32, 1837–49
   PubMedGoogle Scholar
• Kitano A. (1979). Study of experimental ulcerative colitis induced by administration of carrageenan into rabbits. J Osaka Cty Med Cntr, 28, 537--55
   Google Scholar
• Kitano, A, Kobayashi, K, Oshiumi, H, et al. (1981). Studies of experimental ulcerative colitis induced by carrageenan in rabbits. Jap J Gastro, 78, 2104--11
   Google Scholar
• Koletzko B, Baker S, Cleghorn G, et al. (2005). Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr, 41, 584–99
   PubMed Web of Science ®Google Scholar
• Koo J, Weaver CM, Neylan MJ. (1993). Solubility of calcium salts and carrageenan used in infant formulas did not influence calcium absorption in rats. J Pediatr Gastroenterol Nutr, 17, 298–302
   PubMedGoogle Scholar
• MacIntosh, FC. (1941). A colorimetric method for the standardization of heparin preparations. Biochem J, 35, 778–82
   Google Scholar
• Mallett AK, Rowland IR, Bearne CA, Nicklin S. (1985). Influence of dietary carrageenans on microbial biotransformation activities in the cecum of rodents and on gastrointestinal immune status in the rat. Toxicol Appl Pharmacol, 78, 377–85
   PubMed Web of Science ®Google Scholar
• Mallett AK, Wise A, Rowland IR. (1984). Hydrocolloid food additives and rat caecal microbial enzyme activities. Food Chem Toxicol, 22, 415–8
   PubMed Web of Science ®Google Scholar
• Mankes R, Abraham R. (1975). Lysosomal dysfunction in colonic, submucosal macrophages of Rhesus monkeys caused by degraded iota carrageenan (38996). Proc Soc of Exp Biol Med, 150, 166–70
   PubMedGoogle Scholar
• Mankes RF. (1977). Safety evaluation of Iridaea carrageenans in the rat including a study of the mechanisms of liver atrophy [thesis]. Unpublished. Albany Medical College
   Google Scholar
• Marcus SN, Kline TJ, Pothoulakis H, et al. (1990). Role of inflammatory mediators in the pre-ulcerative phase of carrageenan-induced ulcerative disease of the colon. Gastroenterology, 98, A461
   Google Scholar
• Marcus R, Watt J. (1971). Ulceration in young rats fed degraded carrageenan. Lancet, 2, 763--6
   Google Scholar
• Marinalg. (2006). Carrageenan (INS 407) and Processed Euchema Seaweed (INS 407a): Monograph In Response to Request for Data for the 68th Meeting of JECFA, Brussels, Belgium, Nov. 2006. Unpublished report
   Google Scholar
• McGill HC Jr, McMahan CA, Wigodsky HS, Sprinz H. (1977). Carrageenan in formula and infant baboon development. Gastroenterology, 73, 512–7
   PubMedGoogle Scholar
• McKim JM. (2014). Food additive carrageenan: Part I: a critical review of carrageenan in vitro studies, potential pitfalls, and implications for human health and safety. Crit Rev Toxicol, in press
   Google Scholar
• Melnick RL, Huff J, Haseman JK, et al. (1983). Chronic effects of agar, guar gum, gum arabic, locust-bean gum, or tara gum in F344 rats and B6C3F1 mice. Food Chem Toxicol, 21, 305–11
   PubMed Web of Science ®Google Scholar
• Michel C, MacFarlane GT. (1996). Digestive fates of soluble polysaccharides from marine macroalgae: involvement of the colonic microflora and physiological consequences for the host. J Appl Bacteriol, 80, 349–69
   PubMedGoogle Scholar
• Millet AS, Verhaeghe E, Preclaire M, et al. (1997). Carrageenan K, a food gelling agent, promotes the growth of microadenomae in the colon in conventional rats but not in gnotoxenic rats with human flora. In: Fifth Toulouse symposium, Munich, 30 April–4 May, 67
   Google Scholar
• Moirano A. (1977). Sulfated seaweed polysaccharides. In: Graham H, ed. Food colloids. Chapter 8. New York: AVI Publishing Company, 347--81
   Google Scholar
• Mori H, Ohbayashi F, Hirono I, et al. (1984). Absence of genotoxicity of the carcinogenic sulfated polysaccharides carrageenan and dextran sulfate in mammalian DNA repair and bacterial mutagenicity assays. Nutr Cancer, 6, 92–7
   PubMedGoogle Scholar
• Munro IC, Danielewska-Nikiel B. (2006). Comparison of estimated daily intakes of flavouring substances with no-observed-effect levels. Food Chem Toxicol, 44, 758–809
   PubMed Web of Science ®Google Scholar
• Nacife VP, Soeiro M, Gomes RN, et al. (2004). Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo. Cell Struct Funct, 29, 27–34
   PubMed Web of Science ®Google Scholar
• Nicklin S, Baker K, Miller K. (1988). Intestinal uptake of carrageenan: distribution and effects on humoral immune competence. Adv Exp Med Biol, 237, 813–20
   PubMedGoogle Scholar
• Nicklin S, Miller K. (1984). Effect of orally administered food-grade carrageenans on antibody-mediated and cell-mediated immunity in the inbred rat. Food Chem Toxicol, 22, 615–21
   PubMedGoogle Scholar
• Norris AA, Lewis AJ, Zeitlin IJ. (1981). Inability of degraded carrageenan fractions to induce inflammatory bowel ulceration in the guinea-pig. J Pharm Pharmacol, 33, 612--13
   Google Scholar
• Onderdonk AB, Bartlett JB. (1979). Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr, 32, 258–65
   PubMed Web of Science ®Google Scholar
• Organization for Economic Co-operation and Development (OECD). (2009a). Guideline 452: chronic toxicity studies, adopted 7 September 2009
   Google Scholar
• Organization for Economic Co-operation and Development (OECD). (2009b). Guideline 453: chronic toxicity\carcinogenicity studies, adopted 7 September 2009
   Google Scholar
• Papanikolaou A, Wang QS, Papanikolaou D, et al. (2000). Sequential and morphological analysis of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis, 21, 1567–72
   PubMed Web of Science ®Google Scholar
• Pittman KA, Golberg L, Coulston F. (1976). Carrageenan: the effect of molecular weight and polymer type on its uptake, excretion and degradation in animals. Food Cosmet Toxicol, 14, 85–93
   PubMedGoogle Scholar
• Poulsen E. (1973). Short-term peroral toxicity of undegraded carrageenan in pigs. Food Cosmet Toxicol, 11, 219–77
   PubMedGoogle Scholar
• Reddy BS, Watanabe K, Sheinfil A. (1980). Effect of dietary wheat bran, alfalfa, pectin and carrageenan on plasma cholesterol and fecal bile acid and neutral sterol excretion in rats. J Nutr, 110, 1247–54
   PubMed Web of Science ®Google Scholar
• Riccardi BA, Fahrenbach MJ. (1965). Hypocholesterolemic activity of mucilaginous polysaccharides in white leghorn cockerels. Fed Prod, 24, 263
   Google Scholar
• Roberts MA, Quemener B. (1999). Measurement of carrageenans in food: challenges, progress, and trends in analysis. Food Sci Technol, 70, 169–81
   Google Scholar
• Roch-Arveiller M, Giroud JP. (1979). Effects biologiques et pharmaologiques da la carragenine. Path Biol, 27, 615–25
   PubMedGoogle Scholar
• Rovasio RA, Monis B. (1980). Lethal and teratogenic effects of lambda carrageenan, a food additive, on the development of the chick embryo. Toxicol Pathol, 8, 14–9
   Google Scholar
• Rovasio RA, Monis B. (1987). Carrageenan induces anomalies in the chick embryo. A light microscope study. Toxicol Pathol, 15, 444–50
   PubMedGoogle Scholar
• Rowland IR, Mallett AK. (1986). Dietary fiber and the gut microflora – their effects on toxicity. Toxicol Environ Sci, 12, 125–38
   PubMedGoogle Scholar
• Rowland IR, Mallett AK, Bearne CA, Farthing MJ. (1986). Enzyme activities of the hindgut microflora of laboratory animals and man. Xenobiotica, 16, 519–23
   PubMed Web of Science ®Google Scholar
• Rustia M, Shubik P, Patil K. (1980). Lifespan carcinogenicity test with native carrageenan in rats and hamsters. Cancer Lett, 11, 1–10
   PubMed Web of Science ®Google Scholar
• Salyers AA, West SEH, Vercellotti J, Wilkins TD. (1977). Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol, 34, 529–33
   PubMed Web of Science ®Google Scholar
• Scientific Committee for Food on Emulsifiers, Stabilizers, Thickeners and Gelling Agents, 30 November 1978
   Google Scholar
• Shah ZC, Huffman FG. (2003). Current availability and consumption of carrageenan-containing foods. Ecol Food Nutr, 42, 357–71
   Web of Science ®Google Scholar
• Sherry B, Flewelling A, Smith AL. (1993). Carrageenan: an asset or detriment in infant formula? Am J Clin Nutr, 58, 715
   PubMed Web of Science ®Google Scholar
• Sherry B, Flewelling A, Smith AL. (1999). Carrageenan: an asset or detriment in infant formula? Am J Clin Nutr, 58, 715, 1993. Erratum: Am J Clin Nutr, 69, 1293
   Google Scholar
• Sylianco CYL, Balboa J, Serrame E, Guantes E. (1993). Non-genotoxic and antigenotoxic activity of PNG carrageenan. Phillip J Sci, 122, 139–53
   Google Scholar
• Taché S, Peiffer G, Millet AS, Corpet DE. (2000). Carrageenan gel and aberrant crypt foci in the colon of conventional and human flora-associated rats. Nutr Cancer, 37, 193–7
   PubMed Web of Science ®Google Scholar
• Tarlo SM, Dolovich J, Listgarent C. (1995). Anaphylaxis to carrageenan: a pseudo-latex allergy. J Allergy Clin Immunol, 95, 933–6
   PubMed Web of Science ®Google Scholar
• Thomas WR. (1999). In: Imeson A, Thickening and gelling agents for food. Chapter 3. 2nd ed. Aspen Publishers, 45--59
   Google Scholar
• Thompson AW. (1978). Carrageenan and the immune response. Biomedicine, 28, 148–52
   PubMedGoogle Scholar
• Thompson AW, Fowler EF. (1981). Carrageenan: a review of its effects on the immune system. Agents Act, 11, 265–73
   PubMedGoogle Scholar
• Thompson AW, Fowler EF, Pugh-Humphreys RGP. (1979). Immunopharmacology of the macrophage-toxic agent carrageenan. Int J Immunopharm, 1, 247–61
   PubMedGoogle Scholar
• Tobacman JK. (2001). Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect, 109, 983–94
   PubMed Web of Science ®Google Scholar
• Tobacman JK. (2002). Carrageenan in foods: response. Environ Health Perspect, 110, A176–7
   PubMed Web of Science ®Google Scholar
• Tobacman JK. (2003). Toxic considerations related to ingestion of carrageenan. Rev Food Nutr Toxicity, 1, 204–29
   Google Scholar
• Tomarelli RM, Tucker WD Jr, Baumann LM, et al. (1974). Nutritional quality of processed milk containing carrageenan. J Agri Fd Chem, 22, 819–24
   PubMedGoogle Scholar
• Tsuji RF, Hosino K, Noro Y, et al. (2003). Suppression of allergic reaction by λ-carrageenan: toll-like receptor 4/MyD88-dependent and -independent modulation of immunity. Clin Exp Allergy, 33, 249–58
   PubMed Web of Science ®Google Scholar
• Tungland BC, Meyer D. (2002). Nondigestible oligo- and polysaccahrides (dietary fiber): their physiology and role in health and food. Comprehen Rev Food Sci Food Saf, 3, 73–92
   Google Scholar
• Tye RJ. (1991). Carrageenan as a product ingredient. DCI 28–33
   Google Scholar
• United Stated Adopted Names Council (USAN). (1988). List No. 297 New Names, Poligeenan. Clin Pharmacol Therapeut, 44, 246–8
   Google Scholar
• Uno Y, Omoto T, Goto Y, et al. (2001a). Molecular weight and fecal excreted quantity of carrageenan administered to rats in blended feed. Jpn J Food Chem (JJFC), 8, 83–93
   Google Scholar
• Uno Y, Omoto T, Goto Y, et al. (2001b). Molecular weight distribution of Carrageenans studied by a combined gel permeation/inductively coupled plasma (GPC/ICP) method. Food Add Contamin, 18, 763–72
   PubMed Web of Science ®Google Scholar
• Van der Waaij, D, Cohen, BJ, Anver, MR. (1974). Mitigation of experimental inflammatory bowel disease in guinea-pigs by selective elimination of the aerobic gram-negative intestinal microflora. Gastroenterology 67, 460--72
   Google Scholar
• Vorhees CV, Butcher RE, Brunner RL, Sobotka JJ. (1979). A developmental test battery for neurobehavioral toxicity in rats: a preliminary analysis using monosodium glutamate, calcium carrageenan and hydroxyurea. Toxicol Appl Pharmacol, 50, 267–82
   PubMed Web of Science ®Google Scholar
• Watanabe K, Reddy BS, Wong CQ, Weisburger JH. (1978). Effect of dietary undegraded carrageenan on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea. Cancer Res, 38, 4427–30
   PubMed Web of Science ®Google Scholar
• Watt J, Marcus R. (1969). Ulcerative colitis in the guinea pig caused by seaweed extract. J Pharm Pharmacol, 21, 187s--8s
   Google Scholar
• Watt J, Marcus R. (1971). Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut, 12, 164--71
   Google Scholar
• Watt J, Marcus AJ. (1978). Comparison of the effects of carrageenins and Danish agar on the colon of guinea-pigs. Proc Nutr Soc, 37, 39A
   Google Scholar
• Weiner ML. (1988). Intestinal transport of some macromolecules in food. Food Chem Toxicol, 26, 867–80
   PubMed Web of Science ®Google Scholar
• Weiner ML. (1991). Toxicological properties of carrageenan. Agents Act, 32, 46–51
   PubMedGoogle Scholar
• Weiner ML, Freeman C, McCarty JD, Fletcher MJ. (1989). Acute toxicity of carrageenan. Fifth International Congress of Toxicology, 52, 16–21 July
   Google Scholar
• Weiner ML. (2007). Response to JECFA on the Exposure of Adults and Infants to Carrageenan in food and infant formula. Unpublished paper, JECFA, 2007.
   Google Scholar
• Weiner, ML, Nuber D, Blakemore WR, et al. (2007). A 90-day dietary study of kappa carrageenan with emphasis on the gastrointestinal tract. Food Chem Toxicol, 45, 98–106
   PubMedGoogle Scholar
• Willett WC, Hunter DJ, Stampfer MJ, et al. (1992). Dietary fat and fiber in relation to risk of breast cancer. J Am Med Assoc, 268, 2037–44
   PubMed Web of Science ®Google Scholar